Molecular Formula | C10H11NO2 |
Molar Mass | 177.2 |
Density | 1.1607 (rough estimate) |
Melting Point | 86-88°C(lit.) |
Boling Point | 309.12°C (rough estimate) |
Specific Rotation(α) | -62 º (C=1, CHCl3) |
Water Solubility | Insoluble in water. |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Appearance | White to yellow crystals |
Color | White to very slightly yellow |
BRN | 3649667 |
pKa | 12.78±0.40(Predicted) |
Storage Condition | Inert atmosphere,Room Temperature |
Sensitive | Hygroscopic |
Refractive Index | -14.5 ° (C=5, MeOH) |
MDL | MFCD00064496 |
Physical and Chemical Properties | Melting Point: 87 - 90 ℃ |
Use | Pharmaceutical Intermediates, mainly used in asymmetric Chiral synthesis |
Hazard Symbols | Xi - Irritant![]() |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S24/25 - Avoid contact with skin and eyes. S36 - Wear suitable protective clothing. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
FLUKA BRAND F CODES | 3-10 |
HS Code | 29349990 |
Overview | (S)-4-benzyl-2-oxazolidinone is a pharmaceutical intermediate, from (S)-4-benzyl -3-((R)-2-n-propyl-pent-4-enoyl) the oxazol-2-one was obtained by a two-step preparation. |
uses | pharmaceutical intermediates, mainly used in asymmetric Chiral synthesis used as pharmaceutical intermediates pharmaceutical intermediates, chiral auxiliary for asymmetric Chiral synthesis; Asymmetric alkylation reaction chiral auxiliary; Chiral auxiliary for synthesis of (S)-equol, for preparation and functionalization of chiral, stable Ye Lide; For (3R) asymmetric Synthesis of-and (3S)-piperazine-2-carboxylic acid |